DEADLINE: JANUARY 30
There are now opportunities for exciting careers at PREMIUM TIMES, Nigeria’s leading investigative newspaper.
We are inviting candidates who consider themselves experienced, competent, energetic and intrepid enough to be part of our team.
Ideal candidates should have high-level ability:
— To spot grammatical and factual errors and clean up copies
— To identify stronger or more relevant angles buried within stories sent by reporters and others
— To properly contextualize reports
— To enrich reports with historical background, analyses and contexts
— To accurately interpret statements or comments even when missed by reporters
ALSO READ: What journalism practice of over 30 years taught me ― Otufodunrin [2]
Candidates must also:
– Be change agents
– Possess strong writing skills
– Have aversion for corruption
– Have good interpersonal relations skills
– Possess inquiring minds and logical reasoning
Interested candidates should apply before January 30, 2020.
Applications, which should include resumes and writing samples, should be addressed to:
Human Resources Department
Premium Times Services Limited
53 Mambolo Street
Wuse Zone 2, Abuja
Applications can also be emailed to hr@premiumtimesng.com.
Only shortlisted candidates will be contacted.
DEADLINE: JUNE 14, 2026 — Applications are currently open for the 2026 Kurt Schork Awards in International Journalism, an annual programme…
DEADLINE: MAY 30, 2026 — Applications are open for the 2026 Nigeria Media Merit Award (NMMA). The award is for…
DEADLINE: MAY 27, 2026 — The Media Foundation for West Africa (MFWA) seeks an experienced editor for its 12-month investigative journalism…
DEADLINE: JUNE 16, 2026 — Bloomberg News is looking for a Breaking News Editor to join its team in Johannesburg…
DEADLINE: MAY 15, 2026 — Student journalists, fact-checkers and OSINT enthusiasts across Nigerian campuses can apply for the maiden Muneer Yakub…
If you’re planning your next career move, these 5 media opportunities for journalists in May offer timely chances to secure…
This website uses cookies.